The toxicity of 10 plant essential oils to adults of acaricide-susceptible, chlorfenapyrresistant (CRT-53), fenpropathrin-resistant (FRT-53), pyridaben-resistant (PRT-53), and abamectinresistant (ART-53) strains of Tetranychus urticae Koch (Acari: Tetranychidae) and to female Neoseiulus californicus McGregor (Acari: Phytoseiidae) was examined using spray or vapor-phase mortality bioassays. In bioassay with the susceptible adults, lemon eucalyptus (19.3 µg/cm3) was the most toxic oil, followed by peppermint, citronella Java, thyme red, caraway seed, clove leaf, and pennyroyal oils (LC50, 20.6–23.7 µg/cm3). The toxicity of these oils was almost identical against adults from either of the susceptible and resistant strains, even though CRT-53, FRT-53, PRT-53, and ART-53 adults exhibited high levels of resistance to chlorfenapyr (resistance ratio [RR], >9,140), fenpropathrin (RR, 94), pyridaben (RR, >390), and abamectin (RR, 85), respectively, Against female N. californicus, lemon eucalyptus (LC50, 21.4 µg/cm3) was the most toxic oil, whereas the LC50 values of the other nine oils ranged from 23.2 to 72.6 µg/cm3. N. californicus was 1–2 times more tolerant than T. urticae to the test essential oils. Thus, these essential oils merit further study as potential acaricides for the control of acaricide-resistant T. urticae populations as fumigants.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 103 • No. 4